Bal Pharma Ltd. benchmarking: Performance to industry peers

Financial

	Bal Pharma	Smruthi Organics	Tyche Inds
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	1.06 %	3.58 %	1.28 %
Financials
5 yr Average ROE	8.41 %	12.07 %	12.13 %
5yr average Equity Multiplier	4.51	1.54	1.16
5yr Average Asset Turnover Ratio	1.01	1.28	0.53
5yr Avg Net Profit Margin	1.86 %	6.02 %	19.18 %
Price to Book	1.65	1.84	0.98
P/E	15.91	28.39	20.51
5yr Avg Cash Conversion Cycle	27.6 Days	70.37 Days	111.78 Days
Inventory Days	99.82 Days	63.4 Days	69.03 Days
Days Receivable	115.65 Days	105.63 Days	101.01 Days
Days Payable	154.91 Days	96.18 Days	90.14 Days
5yr Average Interest Coverage Ratio	1.5	10.52	2385.83
5yr Avg ROCE	19.2 %	16.62 %	16.3 %
5yr Avg Operating Profit Margin	9.12 %	12.47 %	21.21 %
5 yr average Debt to Equity	1.95	0.14	0.0
5yr CAGR Net Profit	8.78 %	-26.95 %	-9.09 %
5yr Average Return on Assets	1.88 %	8.16 %	10.39 %
Shareholdings
Promoter Holding	50.86 %	64.73 %	61.97 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.75 %	1.15 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Bal Pharma	Smruthi Organics	Tyche Inds
Product Wise Break-Up	Product Wise Break-Up Formulations 52.96 Active Pharmaceutical Ingredient (API) 43.44 0 Manufacture of bulk drugs intermediates 0 Others 3.6	Product Wise Break-Up Manufacture of bulk drugs intermediates 0 Bulk Chemicals 100.0 Formulations 0 Active Pharmaceutical Ingredient (API) 0	Product Wise Break-Up Bulk Chemicals 100.0 0 Formulations 0 Active Pharmaceutical Ingredient (API) 0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 60.58 India 36.5 International 0 Domestic 0 Others 2.92	Location Wise Break-Up India 0 Domestic 46.16 International 53.84 Rest of the World 0	Location Wise Break-Up India 0 Domestic 32.67 International 47.91 Rest of the World 0 Others 19.42